Hib-MenC conjugate vaccine

Haemophilus influenzae type b and Neisseria meningitidis serogroup C conjugate vaccine · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hib-MenC conjugate vaccine, covering 2011-01-14 to 2016-09-21. Get the full timeline:

Most recent: Clinical Trial Update: Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine [Phase 3]